by Chandré Blignaut | Jul 29, 2020 | Featured
A new in vitro study shows the ability of ColdGuardTM to deactivate SARS-CoV-2, the cause of the COVID-19 pandemic ABEX Pharmaceutica has announced that preliminary results of an in vitro study on ColdGuard™ demonstrates that it deactivates SARS-CoV-2 by 98.3%...
by Chandré Blignaut | Jul 27, 2020 | Featured, JEMDSA, News
Uncontrolled diabetes makes the fight against COVID-19 harder Since being declared a global pandemic by the World Health Organization (WHO)[1] earlier this year, COVID-19 cases around the world have continued to increase at an alarming rate with over 11 million[2]...
by Chandré Blignaut | Jul 27, 2020 | Featured, News
dormakaba campaigns for robust hygiene and infection protection access control At this time of social distancing and hygiene control because of the advent of COVID-19, the ability to regulate access in high volume public areas and businesses is critical. Leading...
by Chandré Blignaut | Jul 27, 2020 | Featured
Dementia caregivers must take care of their own mental health during COVID-19, or risk burnout South Africans — and the world — are now months into “shelter at home” decrees, as the novel coronavirus (COVID-19) continues to make its devastating mark on the world. For...
by Chandré Blignaut | Jul 27, 2020 | Featured, News, SAGP, SAJS, SAPJ, WHSA
New affordable broad-spectrum IV antibiotic launched to treat SA’s critically ill South African hospitals will be given a wider choice of high-quality generic intravenous (IV) treatments at a much lower cost – the savings of which will benefit not only SA’s struggling...
